Leading the paradigm shift in pathogen identification
InfectID™-BSI is our first advanced molecular test for the rapid detection and identification of pathogens responsible for sepsis. This innovative solution has been designed to provide clinical intelligence to clinicians and improve patient outcomes by providing accurate and timely results.
Our Latest News
Putting sepsis on notice
26 sepsis-associated pathogens detected in less than 3 hours
Our flagship sepsis assay, InfectID™-BSI, works alongside blood culture to reduce mortality and morbidity in sepsis patients while promoting antimicrobial stewardship.
A new paradigm in pathogen identification
Microbio’s qPCR assay are based on our groundbreaking advances in DNA identification—technology that allows us to discriminate between pathogenic and non-pathogenic organisms even among closely related species.
About Microbio
Microbio is a biotechnology company based in Brisbane, Australia and specialised in the development and manufacturing of innovative diagnostic tools.
The team at Microbio has brought together the latest advances in bioinformatics, genomics and molecular microbiology to develop a unique and revolutionary pathogen identification test and is working tirelessly to deliver their game-changing new test to the millions of patients who will benefit from better pathogen diagnosis.
Resources
